Vanta Bioscience Ltd
Vanta Bioscience | 540729
Share Price Chart - Vanta Bioscience Ltd
Stock Performance
Ratios
About Company
- Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017
- VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries
- In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product
- It also provides expert services for determination of health based exposure limits (e
- permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers
- The Company is established as a center of excellence for GLP toxicology and safety assessment offering services in India and across the globe
- One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world
- Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms
- It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms
- The Company purchased preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as 'Vanta Bioscience' (a toxicology division and commenced commercial activities in April, 2017
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Vanta Bioscience Ltd?
The current share price of Vanta Bioscience Ltd (Vanta Bioscience) is ₹25.29. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Vanta Bioscience Ltd?
The Price-to-Earnings (P/E) ratio of Vanta Bioscience Ltd is 25.29. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Vanta Bioscience Ltd?
Vanta Bioscience Ltd has a 52-week high of ₹31.33 and a 52-week low of ₹14.71. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Vanta Bioscience Ltd?
Vanta Bioscience Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Vanta Bioscience Ltd?
The Earnings Per Share (EPS) of Vanta Bioscience Ltd is ₹0.15. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Vanta Bioscience Ltd?
Vanta Bioscience Ltd has a Return on Equity (ROE) of 0.00%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
